These data suggest that CD11b is closely linked to virus-induced neutrophilic inflammation in COPD exacerbations and CD11b has potential as both a marker and therapeutic target in COPD exacerbations. This evidence concerns the gene ITGAM and chronic obstructive pulmonary disease.